MeSH term
Frequency | Condition_Probility | Aged | 2 | 0.0 |
Humans | 23 | 0.0 |
Time Factors | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Proto-Oncogene Proteins/biosynthesis/genetics | 2 | 2.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Animals | 11 | 0.0 |
Endometrium/*metabolism | 2 | 2.0 |
Female | 13 | 0.0 |
Homeodomain Proteins/*genetics/metabolism | 2 | 2.0 |
Mice | 6 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
*Zebrafish Proteins | 3 | 1.0 |
Conserved Sequence | 3 | 0.0 |
*Genes, Homeobox | 4 | 1.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Adult | 5 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cell Line | 4 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Male | 2 | 0.0 |
Middle Aged | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Oncogene Proteins, Fusion/*genetics | 2 | 1.0 |
Homeodomain Proteins/*genetics | 5 | 1.0 |
Cloning, Molecular | 3 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Phenotype | 3 | 0.0 |
Pregnancy | 6 | 0.0 |
Embryo Implantation/*physiology | 2 | 5.0 |
Amino Acid Sequence | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
